Radiation safety issues with positron‐emission/computed tomography simulation for stereotactic body radiation therapy

por Kearns, William T., Urbanic, James J., Hampton, Carnell J., McMullen, Kevin P., Blackstock, A. William, Stieber, Volker W., Hinson, William H.
Publicado 2008

NRG/RTOG 0837: Randomized, phase II, double-blind, placebo-controlled trial of chemoradiation with or without cediranib in newly diagnosed glioblastoma

por Batchelor, Tracy T, Won, Minhee, Chakravarti, Arnab, Hadjipanayis, Costas G, Shi, Wenyin, Ashby, Lynn S, Stieber, Volker W, Robins, H Ian, Gray, Heidi J, Voloschin, Alfredo, Fiveash, John B, Robinson, Clifford G, Chamarthy, UshaSree, Kwok, Young, Cescon, Terrence P, Sharma, Anand K, Chaudhary, Rekha, Polley, Mei-Yin, Mehta, Minesh P
Publicado 2023

Germline polymorphisms in MGMT associated with temozolomide-related myelotoxicity risk in patients with glioblastoma treated on NRG Oncology/RTOG 0825

por Scheurer, Michael E, Zhou, Renke, Gilbert, Mark R, Bondy, Melissa L, Sulman, Erik P, Yuan, Ying, Liu, Yanhong, Vera, Elizabeth, Wendland, Merideth M, Youssef, Emad F, Stieber, Volker W, Komaki, Ritsuko R, Flickinger, John C, Kenyon, Lawrence C, Robins, H Ian, Hunter, Grant K, Crocker, Ian R, Chao, Samuel T, Pugh, Stephanie L, Armstrong, Terri S
Publicado 2022